JY
TARA icon

Jeff Yass’s Protara Therapeutics TARA Stock Holding History

Jeff Yass’s Portfolio TARA Stock Details TARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$154K Sell
40,380
-76,246
-65% -$363K ﹤0.01% 12185
2026
Q1 		$608K Buy
116,626
+9,780
+9% +$57.9K ﹤0.01% 9159
2025
Q4 		$569K Buy
106,846
+25,643
+32% +$143K ﹤0.01% 8474
2025
Q3 		$353K Sell
81,203
-138,694
-63% -$449K ﹤0.01% 9743
2025
Q2 		$666K Sell
219,897
-54,984
-20% -$190K ﹤0.01% 8497
2025
Q1 		$1.17M Buy
274,881
+56,408
+26% +$252K ﹤0.01% 6860
2024
Q4 		$1.15M Buy
+218,473
New +$706K ﹤0.01% 6602
2024
Q3 		– Sell
-10,036
Closed -$20.9K – 13021
2024
Q2 		$20.9K Sell
10,036
-1,149
-10% -$3.36K ﹤0.01% 11659
2024
Q1 		$44.9K Buy
+11,185
New +$36.1K ﹤0.01% 11597
2023
Q4 		– Sell
-34,971
Closed -$58.4K – 13273
2023
Q3 		$58.4K Buy
+34,971
New +$80.1K ﹤0.01% 11222
2022
Q3 		– Sell
-15,969
Closed -$47K – 14107
2022
Q2 		$47K Buy
15,969
+2,230
+16% +$8.15K ﹤0.01% 12013
2022
Q1 		$70K Sell
13,739
-14,123
-51% -$74.2K ﹤0.01% 12133
2021
Q4 		$188K Buy
27,862
+11,969
+75% +$82.5K ﹤0.01% 11517
2021
Q3 		$110K Sell
15,893
-4,716
-23% -$36.8K ﹤0.01% 12005
2021
Q2 		$201K Buy
+20,609
New +$233K ﹤0.01% 11595
2020
Q2 		– Sell
-18,674
Closed -$441K – 10905
2020
Q1 		$441K Buy
18,674
+18,264
+4,455% +$532K ﹤0.01% 7199
2019
Q4 		$7K Sell
410
-1,491
-78% -$17.1K ﹤0.01% 9568
2019
Q3 		$20K Buy
+1,901
New +$27.2K ﹤0.01% 9950
2019
Q1 		– Sell
-802
Closed -$73K – 9823
2018
Q4 		$73K Buy
+802
New +$56.6K ﹤0.01% 8351
2018
Q2 		– Sell
-307
Closed -$31K – 10405
2018
Q1 		$31K Sell
307
-186
-38% -$16.9K ﹤0.01% 9068
2017
Q4 		$37K Buy
+493
New +$39.5K ﹤0.01% 8986
2017
Q2 		– Sell
-739
Closed -$52K – 9822
2017
Q1 		$52K Buy
+739
New +$55.2K ﹤0.01% 8583

Other funds holding TARA

JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.53B AUM 154.61% 1-Year Est. Return

Jeff Yass's TARA Position: Q2 2026 in Review

Jeff Yass reduced its Protara Therapeutics (TARA) stake by 65% in Q2 2026, selling an estimated $363K and leaving 40,380 shares worth $154K. The position accounts for ﹤0.01% of the portfolio, ranked #12185.

Jeff Yass first reported a position in TARA in Q1 2017 and has held it in 22 quarters since. The position peaked at $1.17M in Q1 2025. 119 funds tracked by Wall St. Rank hold TARA as of Q2 2026.

  • Jeff Yass held 40,380 shares of Protara Therapeutics worth $154K as of Q2 2026.
  • Jeff Yass sold 76,246 Protara Therapeutics shares in Q2 2026, an estimated $363K.
  • Protara Therapeutics made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #12185 holding.
  • Jeff Yass first reported a position in Protara Therapeutics in Q1 2017 and has held it in 22 quarters since.
  • Jeff Yass's Protara Therapeutics position peaked at $1.17M in Q1 2025.
  • 119 funds tracked by Wall St. Rank held Protara Therapeutics as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.